Yogen Saunthararajah

This inventor holds 10 USPTO granted patents and 7 published patent applications, plus 2 CIPO patents and 4 EPO patents. Top assignees: University of Illinois, Epidestiny, Inc., The Cleveland Clinic Foundation. Active years: 2011-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Yogen Saunthararajah. Retrieved from https://idiyas.com/inventor/yogen-saunthararajah

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 10 (Patent Applications = 7)

% Patents Active = 90.0

CIPO Patents = 2 (Patent Applications = 1)

EPO Patents = 4 (Patent Applications = 4)

Average Co-Inventor Count = 2.5

ph-index = 4

Forward Citations = 40(Granted Patents)

Location History:

Chicago, IL (US) (2011)
Cleveland, OH (US) (2016 - 2023)

Company Filing History:

7 out of 2,430

University of Illinois

The Cleveland Clinic Foundation

patents

Years Active: 2011-2026

Loading Chart...

10 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12758569 - Treatment of RNA virus infection with a cytidine deaminase inhibitor (2026-10-13),

2. 11786543 - Compositions comprising decitabine and tetrahydrouridine and uses thereof (2023-10-17),

3. 11779591 - Compositions containing decitabine, 5azacytidine and tetrahydrouridine and uses thereof (2023-10-10),

4. 11376270 - Compositions containing decitabine, 5Azacytidine and tetrahydrouridine and uses thereof (2022-07-05),

5. 11096953 - Compositions comprising decitabine and tetrahydrouridine and uses thereof (2021-08-24),

6. 10517884 - Compositions comprising decitabine and tetrahydrouridine and uses thereof (2019-12-31),

7. 9895391 - Compositions comprising decitabine and tetrahydrouridine and uses thereof (2018-02-20),

8. 9265785 - Compositions comprising decitabine and tetrahydrouridine and uses thereof (2016-02-23),

9. 9259469 - Compositions comprising decitabine and tetrahydrouridine and uses thereof (2016-02-16),

10. 7927785 - Methods for in vitro expansion of hematopoietic stem cells (2011-04-19),

Title: Yogen Saunthararajah: Innovator in Blood Disorder Treatments

Introduction

Yogen Saunthararajah is a notable inventor based in Cleveland, OH (US). He has made significant contributions to the field of medical treatments, particularly in the area of blood disorders and malignancies. With a total of 10 patents to his name, his work has the potential to impact many lives.

Latest Patents

Among his latest patents, one includes compositions comprising decitabine and tetrahydrouridine. This patent describes methods for treating blood disorders and malignancies. In one embodiment, a composition for treatment includes decitabine, tetrahydrouridine, and an excipient. Another embodiment outlines a method for oral administration of this composition, which may be given 1-3 times weekly. Additionally, he has developed compositions containing decitabine, 5-azacytidine, and tetrahydrouridine for cancer treatment. These compositions can be administered in pill form, guided by predictive biomarkers.

Career Highlights

Yogen has worked with esteemed institutions such as the University of Illinois and Epidestiny, Inc. His innovative approaches to treatment have garnered attention in the medical community.

Collaborations

He has collaborated with notable individuals in his field, including Joseph Desimone and Henry Lau. Their combined expertise has contributed to the advancement of his research and inventions.

Conclusion

Yogen Saunthararajah's work in developing treatments for blood disorders and malignancies showcases his dedication to innovation in medicine. His patents reflect a commitment to improving patient outcomes through scientific advancements.

Profile summary based on public USPTO records.